Trademark: 97239358
Word
DECLAMERSE
Status
Registered
Status Code
700
Status Date
Tuesday, March 7, 2023
Serial Number
97239358
Registration Number
6995585
Registration Date
Tuesday, March 7, 2023
Mark Type
4000
Filing Date
Wednesday, January 26, 2022
Published for Opposition
Tuesday, December 20, 2022

Trademark Owner History
Glaxo Group Limited - Original Registrant

Classifications
5 Vaccines; Pharmaceutical preparations and substances for the treatment of damaged skin and tissue; Pharmaceutical preparations for the treatment of infectious diseases, pain, inflammation, obesity and cognitive disorders; Pharmaceutical preparations for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, oncological, hepatological, respiratory, neurological, gastrointestinal, dermatological, psychiatric and immune system related diseases and disorders

Trademark Events
Mar 7, 2023
Notice Of Registration Confirmation Emailed
Mar 7, 2023
Registered-Principal Register
Dec 20, 2022
Official Gazette Publication Confirmation E-Mailed
Dec 20, 2022
Published For Opposition
Nov 30, 2022
Notification Of Notice Of Publication E-Mailed
Nov 16, 2022
Approved For Pub - Principal Register
Nov 9, 2022
Teas Change Of Correspondence Received
Nov 9, 2022
Attorney/Dom.Rep.Revoked And/Or Appointed
Nov 9, 2022
Teas Revoke/App/Change Addr Of Atty/Dom Rep Received
Nov 5, 2022
Assigned To Examiner
Jan 31, 2022
New Application Office Supplied Data Entered
Jan 29, 2022
New Application Entered

Trademark Alertz updated from USPTO on 2030-01-24